Viatris

OVERALL
Owned	USA
Rating

Pharmaceuticals

Created in 2020 when Mylan merged with Pfizer's off-patent drug business, Upjohn.


Viatris Inc	USA	website			twitter

> About the Ratings

Company Assessment

PRAISE

CRITICISM

INFORMATION

Viatris Inc

Environment

CDP Climate Change Score of B-

CDP Water Security Score of B

Business Ethics

76.7/100 in Newsweek rankings

Business Ethics

37.4/125 at JUST Capital

Business Ethics

30/100 S&P Global ESG Score

Business Ethics

Business Ethics

AMR Industry Alliance member

Modern Slavery statement

Business Ethics

OpenSecrets.org profile

> About the Icons

Company Details

Type	Public company
Founded	2020
Revenue	20 billion USD (2020)
Subsidiaries	Mylan NV Pharmaceuticals One the world's largest manufacturers of prescription generic drugs. Merged with Upjohn in 2020 to create Viatris Inc. - Meda AB Pharmaceutical manufacturer and marketer Products are prescription and OTC (over the counter) drugs. Main focus is on sales and marketing and as they do not develop early stage new products, new product growth is by acquisition. Products are sold in more than 150 countries, with own sales companies in 60 countries. Product areas are respiratory, dermatological and pain/inflammation. Acquired by Mylan in 2016. - Alphapharm Pty Ltd Pharmaceuticals Established in 1982. Makers of generic medicines. Alphapharm is the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme. Operates a manufacturing plant in Queensland. Acquired by Mylan in 2007 who merged with Upjohn in 2020 to form Viatris. Bought Aspen's portfolio of prescription and over-the-counter products in Australia for $188 million in 2019.

Contact Details

Address	Delaware, USA
Website	www.viatris.com

Products / Brands

Viatris Australia

Dermeze Skin Care
Dermeze Body Wash
Dymadon Pain Relief Tablets
Gastro-Stop Digestive Care
Irish Moss Cold & Flu
Stingose Antiseptic
Tums Digestive Care
Waxsol Eye & Ear Care
Zantac Digestive Care